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Oxidative stress occurs when reactive oxygen species (ROS) production overwhelms cell protection by antioxidants. This 
review is focused on general anaesthesia-induced oxidative stress because it increases the rate of complications and delays 
recovery after surgery. It is important to know what effects of anaesthetics to expect in terms of oxidative stress, particularly 
in surgical procedures with high ROS production, because their either additive or antagonistic effect may be pivotal for 
the outcome of surgery. In vitro and animal studies on this topic are numerous but show large variability. There are not 
many human studies and what we know has been learned from different surgical procedures measuring different endpoints 
in blood samples taken mostly before and after surgery. In these studies most intravenous anaesthetics have antioxidative 
properties, while volatile anaesthetics temporarily increase oxidative stress in longer surgical procedures.
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Abbreviations
CPB – cardiopulmonary bypass; F2-IsoPs – F2-
isoprostanes; CAT – catalase; GPx – glutathione peroxidase; 
GSH – glutathione; GSHR – glutathione reductase; GST 
– glutathione transferase; HNE – 4-hydroxynonenal; LOO˙ 
– lipidperoxyl radicals; MDA – malondialdehyde; 8-OHdG 
– 8-hydroxydeoxyguanosine; OSI – oxidative stress index; 
PUFA – polyunsaturated fatty acids; ROS – reactive oxygen 
species; SIRS – systematic inflammatory response 
syndrome; SOD – superoxide dismutase; TAC – total 
antioxidative capacity; TAS – total antioxidative status; 
TBARS – thiobarbituric acid reacting substances; TOS – 
total oxidative status
Oxidative stress is the imbalance of reactive oxygen 
species (ROS) production and antioxidative cell defence, 
which disrupts redox signalling and control and causes 
molecular damage (1). It is considered to be involved in the 
process of ageing, inflammations, cancers, degenerative 
diseases (2), and exposure to xenobiotics and drugs, such 
as anaesthetics (3). Anaesthetics-induced oxidative stress 
may affect lipids, proteins, and DNA. Among them, the 
most susceptible to oxidation are lipids (4). ROS interact 
with polyunsaturated fatty acids (PUFA) to form highly 
reactive lipoperoxides. Oxidative attack on lipids may result 
in the production of aldehydes such as 4-hydroxynonenal 
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(HNE) and malondialdehyde (MDA) or prostaglandin-like 
compounds called F2-isoprostanes (F2-IsoPs) (5). 
Anaesthetics-related oxidative stress is most often measured 
as plasma MDA levels or thiobarbituric acid reacting 
substances (TBARS) (6).
Oxidative damage to proteins results in their functional 
impairment or loss and in increased susceptibility to 
proteases (7, 8). Biomarkers of oxidative stress of proteins 
are carbonyl groups introduced into amino acid side chains, 
but they are not measured frequently in studies on 
anaesthetics-induced oxidative stress.
DNA damage is established by upregulation of 
8-hydroxydeoxyguanosine (8-OHdG) and migration of 
broken DNA measured either by single-cell gel 
electrophoresis (comet assay) or more specific comet assays 
such as formamidopyridine DNA N-glycolase (Fpg) or 
enzyme-modified and human 8-oxoguanine DNA 
glycosylase (hOGG1) comet assay. In human studies DNA 
damage is measured in peripheral blood lymphocytes. In 
animal studies measurements may involve other organs as 
well.
Oxidative stress can be prevented or decreased by 
natural cell antioxidant defence, which transforms highly 
reactive oxygen species to less reactive compounds. Among 
numerous antioxidants the most frequently measured are 
glutathione (GSH), superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GPx), glutathione reductase 
(GSHR), and glutathione transferase (GST).
Other biomarkers of oxidative stress include total 
antioxidant status (TAS), total oxidative status (TOS), and 
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oxidative stress index (OSI). OSI is the ratio between TOS 
and TAS and indicates the level of oxidative stress.
Surgery patients undergo procedures that can cause 
surgical trauma, inflammation, and ischaemia-reperfusion 
injury, all of which cause oxidative stress (9–11). To avoid 
further tissue injury caused by anaesthetics, it is very 
important to choose the ones that would minimise oxidative 
stress. This review seeks to summarise the effects of the 
most common intravenous and inhalation (volatile) 
anaesthetics in terms of oxidative stress and related 
genotoxic potential. We relied on preclinical (in vitro and 
animal) and available clinical data. Even though they are 
often inconclusive and even controversial, because the 
experiments greatly vary in cell cultures, animal species, 
concentrations, times of exposure, and different end-points, 
our goal was to find common grounds that could provide 
some informed advice to anaesthetists and surgeons.
INTRAVENOUS ANAESTHETICS
Propofol
Propofol (2,6-diisopropylphenol) is a widely used 
anaesthetic with many favourable properties. It reduces 
intracranial pressure and prevents inflammation and 
convulsions (12). Its pharmacokinetics in adults has been 
aptly described by Kanto and Gepts (13) and in children by 
Rigby-Jones and Sneyd (14). Children have higher 
clearance than adults and need higher induction and 
maintenance doses to achieve the same propofol blood 
concentration.
As propofol contains a phenolic OH-group, in vitro 
studies suggest that it has a high potential to prevent lipid 
peroxidation (15) by scavenging lipidperoxyl radicals 
(LOO˙) and could replace α-tocopherol in that respect (16). 
It also seems to strengthen the GSH system in rat cells by 
inhibiting GPx and increasing GSHR and GST activity (17).
Genotoxicity studies seem to agree that propofol does 
not damage DNA. In primary rat astroglial cells it has been 
reported to protect DNA from lesions by scavenging 
peroxynitrite (18). In patients who underwent ear surgery 
propofol did not cause DNA damage in peripheral blood 
lymphocytes (19, 20). Similar was reported for 21 patients 
who underwent open-heart surgery and showed no increase 
in chromosomal aberrations of peripheral blood lymphocytes 
(21).
In rat studies in vivo, propofol has been reported to 
protect from kidney (22), heart (23), and liver ischaemia/
reperfusion injury (24), decrease lipid peroxidation in the 
spinal cord after injury (25), attenuate postoperative signs 
of organ injury after liver transplantation (26, 27), protect 
from obstructive jaundice (28), hepatocyte necrosis, and 
infiltration of inflammatory cells, and restore liver 
architecture after halothane-induced intoxication (29).
In dogs anaesthetised with propofol, however, findings 
are less straightforward regarding total antioxidant capacity 
(TAC). One study reported unchanged TAC up to 48 h after 
gas evacuation for pneumoperitoneum (30), and another 
study a significant decrease in TAS with unchanged TOS 
at the end of anaesthesia for laparotomy and gastrotomy, 
which resulted with significant increase in OSI (TOS and 
TAS ratio) (31). A study on rats did not give consistent 
results regarding plasma TBARS, GSH/GSSG, SOD, CAT, 
and GSHR (32).
Findings in humans are generally favourable. One study 
(33) showed no significant plasma MDA changes in 29 liver 
donors anaesthetised with propofol before and after surgery. 
Another study (19) in 15 patients who underwent minor 
surgery and were receiving propofol anaesthesia for two 
hours showed increased plasma TAS and tocopherol 
concentrations, which confirmed its antioxidative 
properties. One clinical trial (34) comparing 50 patients 
under propofol anaesthesia and 50 patients on ketamine 
reported lower blood lipid peroxidation, GPx, and SOD 
activity in the first group. In 10 children with acyanotic 
heart disease, plasma MDA, GSH, lactate, and pyruvate 
concentrations remained unchanged after surgery (35). One 
study with 12 patients who underwent laparoscopic 
cholecystectomy (36) showed a significant drop in plasma 
MDA 1 min before desufflation and 20 min after desufflation 
when compared with concentrations before insufflation. In 
contrast, another study (37) reported higher plasma MDA 
concentrations in patients (N=17) undergoing partial 
hepatectomy after 60 min of propofol anaesthesia. These 
returned to preoperative values 24 h after surgery. A 
comparative study in patients with radical oesophagectomy 
showed significantly lower incidence of severe postoperative 
complications with propofol (7 of 92) than with sevoflurane 
anaesthesia (18 of 94) (P=0.03) (38).
Because of its antioxidative properties, propofol has, in 
fact, been proposed for application other than anaesthetic 
and sedative. In cultured neonatal rat cardiomyocytes it 
reduced doxorubicin-induced stress, and the authors of the 
study suggested that it could be used as adjuvant in 
doxorubicin therapy (39). It was also suggested for the 
treatment of glioblastoma, as it triggered apoptosis in human 
brain glioblastoma multiforme cells by decreasing Bcl-2 
and increasing Bax and caspase activity (40). It also showed 
beneficial effects in critically ill patients with systemic 
inflammatory response and sepsis (41).
Thiopental
Thiopental or penthiobarbital (2-thio-5-ethyl-5-sec-
pentylbarbituric acid) is a rapid-onset short-acting general 
anaesthetic. Even though it has largely been replaced by 
propofol, it is still used for rapid induction of anaesthesia 
in emergency cases. Research of its antioxidative and 
immunomodulating properties in human neutrophils 
showed a significant drop in O2
-, H2O2, and OH
 levels in the 
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presence of clinically relevant thiopental plasma 
concentrations (30 µg/L) (42). Thiopental also showed 
anti-inflammatory properties by significantly reducing 
chemotaxis and phagocytosis (43).
Animal studies of thiopental effects on oxidative stress 
report uneven findings. In rats with spinal cord contusion 
injury it showed beneficial effects, because spinal cord 
MDA was significantly lower than in control rats not treated 
with thiopental (25). In another study (44), in contrast, rats 
showed higher MDA and lower GSH, GPx, and GSHR 
levels in brain, heart, and bronchial tissues. In dogs with 
surgical trauma thiopental significantly increased plasma 
TOS, while TAS remained unchanged, which resulted with 
increased OSI (31).
In humans, the study with patients who underwent 
laparoscopic cholecystectomy (36) showed no changes in 
plasma MDA throughout the whole procedure, which 
suggests antioxidative effects of thiopental.
Ketamine
Ketamine (C13H16ClNO) is an N-methyl-D-aspartate 
(NMDA) receptor antagonist (45).
In vitro, ketamine was reported to produce toxic effects 
only at levels much higher than those corresponding to 
anaesthetic concentrations (46, 47). When they did 
correspond to plasma concentrations in anaesthesia (30 µg/
mL), human neutrophil ROS (O2
-, H2O2, and OH) production 
did not differ from controls (43).
In rats, ketamine showed protective effects against 
oxidative stress. In fact, ketamine anaesthesia resulted in 
significantly lower kidney and liver tissue MDA than 
propofol, thiopental, and fentanyl (28, 48). In another study 
(44), the authors attributed significantly higher MDA and 
lower GSHR and GPx levels to ketamine-triggered boost 
of adrenaline, which is known to induce oxidative stress 
(49). In mice, ketamine also turned out to mitigate 
(secondary) brain injury which occurs when ROS 
production overwhelms the antioxidant system (50). It 
lowered brain MDA content in these mice and increased 
GPx, SOD, and NRf2 activity. These effects were 
accompanied by a significant reduction of brain water 
content and improved brain function (grip test) score.
Reports of ketamine effects in humans are positive. In 
adult and paediatric patients with cardiopulmonary bypass 
(CPB) ketamine mitigated the systemic inflammatory 
response syndrome (SIRS) by reducing proinflammatory 
IL-6 and IL-8, and/or increasing anti-inflammatory IL-10 
(51–53).
Etomidate
Etomidate (R-1-(1-ethylphenyl)imidazole-5-ethyl ester) 
is a short-acting intravenous anaesthetic, whose R (+) 
enantiomer has a much higher hypnotic activity than the S 
(-) enantiomer (54). It has been in clinical use since 1972 
thanks to high therapeutic index and minimal effects on 
blood pressure and breathing. However, its use as 
anaesthetic has been limited since reports of serious 
adrenocortical suppression and myoclonus were published 
(55). It is no longer used to induce anaesthesia in critically 
ill patients, because adrenal suppression decreases cortisol 
release and thus weakens anti-inflammatory response. This 
means longer stays at intensive care units and higher 
mortality rate (56).
In vitro, etomidate does not affect TBARS production 
and the glutathione defence system (GPx, GSHR, GST) 
(17).
Similar was observed in animal studies. It does not seem 
to affect MDA levels or change SOD activity (57) in rat 
brain, while it significantly decreased MDA and increased 
GSH levels in the spinal cord after injury (58).
In human studies, its effect on plasma MDA was 
compared with that of thiopental and propofol. In patients 
who underwent laparoscopic cholecystectomy it fared 
worse than either (36), as it increased MDA levels before 
and after desufflation compared to other anaesthetics. In 
another study with 60 patients who underwent tibial fracture 
surgery (59) etomidate did not affect SOD activity, and 
patients receiving it had shorter hospitalisation time because 
of fewer postoperative complications such as numbness, 




Sevoflurane [f luoromethyl-2,2,2tr if luoro-1-
(trifluoromethyl) ethyl ether] has been used for general 
anaesthesia since the 1990s. It has a lower blood-gas 
partition coefficient than other volatile anaesthetics, which 
allows rapid induction of anaesthesia and quick reawakening. 
Because it does not cause irritation, acts as bronchodilator, 
and barely has any smell, it is the anaesthetic of choice in 
children (60), especially those with respiratory infections, 
airway hyper-reactivity, and seasonal allergies (61).
Genotoxicity studies point to none to low DNA damage. 
In one study (62), alkaline comet assay showed no 
sevoflurane genotoxicity in human peripheral lymphocytes, 
but in another (63) DNA damage was found in kidney 
homogenates of rats exposed for two hours over three 
consecutive days. Excessive exposure in this experiment 
may explain why the comet tail length and intensity 
increased gradually until the end of experiment (24 h). In 
peripheral lymphocytes of patients who underwent 
minimally invasive surgery that lasted two hours, the assay 
revealed no DNA damage (20), and no damage was reported 
in peripheral lymphocytes of children under sevoflurane 
anaesthesia for about one hour (64). In patients with lower 
abdominal surgery DNA damage was short-lived and tail 
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parameters started to return to normal on the third day, and 
repair was complete five days after anaesthesia (65).
In animal studies, findings of its effects on oxidative 
stress parameters vary, however. One study (66) reported 
higher GST and SOD activity and TBARS level in the liver 
of young and adult female rats after sevoflurane anaesthesia. 
In adult male rats it also increased MDA in the lungs, but 
decreased it in the kidney and brain (67). It also significantly 
reduced liver MDA levels in rats with ischaemia/reperfusion 
injury (57). Compared to isoflurane in another study (68), 
it produced significantly lower TBARS levels.
Several human studies suggest that sevoflurane does 
not increase oxidative stress, especially in minor surgeries 
(3), and where it does (as in major surgeries such as 
orthopaedic, cholecystectomy, hysterectomy, and alike) 
oxidative stress parameters return to normal 24–48 h after 
exposure has stopped. In patients who underwent 
laparoscopic surgery it did not increase plasma MDA and 
protein carbonyls (69) nor did it affect MDA, GSH, lactate, 
and pyruvate levels in peripheral blood of ten acyanotic 
children who underwent elective cardiac surgery (35) or 
GPx activity and TOS in 15–50-year-old patients who 
underwent laparoscopic cholecystectomy (70), while their 
TAS significantly increased. In a study of 12–36 months 
old children undergoing hypospadias repair surgery (71) 
sevoflurane increased SOD, GPx, and caspase-3 mRNA 
levels two hours after surgery, but these returned to normal 
three days later. The authors conclude that sevoflurane 
temporarily increases oxidative stress in children.
Desflurane
Desflurane (1,2,2,2-tetrafluoroethyl difluoromethyl 
ether) has the blood-gas partition coefficient lower than any 
other anaesthetic, which grants rapid recovery from general 
anaesthesia. It is contraindicated in children because of its 
pungent smell, which makes children hold their breath, 
cough, and salivate profusely (61).
Animal studies report controversial findings. One study 
comparing the effects of desflurane on oxidative stress in 
pig peripheral blood and bronchoalveolar lavage (BAL) 
fluid with those of sevoflurane and propofol (72) reported 
significantly higher MDA levels and lower GPx activity. 
Another, comparing it with sevoflurane, reported no brain 
accumulation of IL-6 and TNF-a or cognitive impairment 
in six days old mice (73).
Clinical studies also report inconclusive findings. In 
mothers with elective Caesarean section serum TOS and 
OSI were significantly lower after surgery than before it 
(74), but compared to sevoflurane, these parameters were 
significantly higher, especially in umbilical artery blood, 
which also had higher LOOH. In patients with laparoscopic 
cholecystectomy (70) it increased total oxidant capacity, 
but did not affect TAS and GPx activity. Similar were the 
findings reported for Turkish patients who underwent 
unspecified elective surgery (75): while serum GPx and 
erythrocyte SOD activity did not change, MDA levels 
soared, and α-tocopherol plummeted in the first hour after 
surgery, but both returned to baseline values 12 h later. This 
transitory increase in MDA and protein carbonyl content 
was also reported six hours after desflurane anaesthesia 
(given together either with fentanyl or N2O), which started 
to returned to normal 24 h later (69).
As for its genotoxic potential, one study reports that 
desflurane does not cause DNA damage if used for minor 
surgeries for at least 90 minutes (76), while another study 
(77) revealed significantly higher 8-OHdg concentrations 
in plasma samples in addition higher comet tail length and 
intensity in BAL samples taken after anaesthesia, which 




trifluoro-ethane) has been used as anaesthetic since the 
1980s (3, 20) thanks to particularly (s)low metabolism and 
solubility, which results in very short induction and recovery 
time.
Isoflurane has antioxidative properties in vitro (3, 78), 
but in vivo it induces oxidative stress by increasing lipid 
peroxidation (68). In an animal experimental model 
simulating liver transplantation isoflurane induced 
significantly higher TBARS levels than sevoflurane.
Clinical studies evidence some oxidative stress. In one, 
isoflurane increased plasma MDA in patients undergoing 
donor hepatectomy, but it did not affect TOS, TAC, and 
SOD activity (33). Plasma SOD and GPx activities were 
also not affected in another study (79).
Genotoxicity/mutagenicity studies generally suggest no 
effects (77, 80), especially not after a minor surgery (19, 
20). However, after a major lower abdominal surgery, one 
study (65) reported significantly increased comet assay 
parameters in peripheral blood lymphocytes two hours after 
the beginning of isoflurane anaesthesia. These parameters 
returned to normal three days later.
Nitrous oxide
Having the lowest potency among inhalational 
anaesthetics, nitrous oxide (N2O) is often combined with 
more powerful ones (81) or used as anxiolytic. As it does 
not cause addiction but causes brief (several minutes long) 
bursts of euphoria, dissociation, and excitement, it is not 
prohibited by law, and people have also been using it for 
recreational purposes ever since 1775 (laughing gas parties) 
(82).
Even so, its use as anaesthetic has been in decline over 
postoperative nausea and vomiting, which are more 
pronounced if used for more than one hour (83). However, 
the European Society of Anaesthesiology believes that its 
benefits outweigh the adverse effects and find no real 
arguments to abandon it.
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N2O is not mutagenic in bacterial and mammalian cell 
systems (84). It is teratogenic to embryos of pregnant 
animals exposed to high doses of N2O for 24 h during 
organogenesis but is not carcinogenic (76, 84). However, 
one study in nurses showed a positive correlation between 
the level of exposure to N2O and oxidative DNA damage 
measured with the Fpg-modified comet assay (85). These 
nurses also had significantly higher lymphocyte ROS and 
plasma and urine TBARS levels and lower GPx activity 
than unexposed healthcare workers.
It is known that N2O irreversibly inactivates methionine 
synthase (86), which leads to increased concentrations of 
homocysteine in plasma (87), which, in turn, inhibits the 
expression of antioxidant enzymes, including GPx. This 
effect can be counteracted by oral vitamin therapy (folate 
2.5 mg, B6 25 mg and B12 500 mg) for one week before 
surgery (88). In addition, N2O causes endothelial 
dysfunction in patients with cardiovascular disease 
undergoing non-cardiac surgery, which, in turn, increases 
the risk of postoperative cardiac events and mortality (87). 
One clinical study in patients anaesthetised with desflurane 
with or without N2O (76) found no difference in lipid 
peroxidation, protein carbonyls, DNA damage, and ferric-
reducing antioxidant power, which indicates that N2O does 
not increase oxidative stress.
Volatile anaesthetic developmental neurotoxicity
One specific aspect of concern with anaesthetics – and 
particularly with sevoflurane, which is the most frequently 
used anaesthetic in paediatric surgery – is their neurotoxic 
potential. Considering that anaesthetics are lipophilic and 
readily pass the placental barrier, they may cause brain 
injury in foetuses and children. Judging by animal model 
studies (reviewed in ref. 89), exposure to sevoflurane during 
uterine quiescence can induce neuroinflammation, 
neuroapoptosis, and eventually memory impairment. 
Cognitive impairment was also reported in young mice 
repeatedly exposed to sevoflurane, which caused an increase 
in proinflammatory proteins IL-6 and TNF-α (73). IL-6 and 
Nrf2 were also increased in rats exposed to sevoflurane for 
five hours (90). Another review article (91) of preclinical 
intervention studies in neonatal mice suggests that volatile 
anaesthetics can lead to oxidative stress-related acute 
neurotoxicity and learning and memory deficits later in life. 
The risks of attention deficit, hyperactivity disorder, 
disabilities in language acquisition, and disabilities in 
abstract reasoning after prolonged anaesthesia have also 
been highlighted in a review article by Olsen and Brambrink 
(92). However, a randomised multicentre controlled trial 
following up 722 children for two and five years (93) after 
their one-hour general anaesthesia reported no significant 
neurocognitive or behavioural deficits.
CONCLUSIONS
Research of oxidative/antioxidative effects of 
anaesthetics has produced ambiguous findings so far, which 
stem from differences in exposure related to specific 
surgical procedures, length of anaesthesia, and timing of 
blood and tissue sampling. Even so, intravenous anaesthetics 
generally have antioxidant properties and short exposure 
to volatile anaesthetics does not seem to increase oxidative 
stress, while the effects of longer exposure are transient. 
Transient anaesthetics-induced oxidative stress may be the 
most relevant for the outcome of surgery with procedures 
that cause oxidative stress themselves. In such cases 
anaesthetics with antioxidative properties are drugs of 
choice.
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Oksidacijski stres uzrokovan općom intravenskom i inhalacijskom anestezijom
Ovo je pregledni rad o oksidacijskom stresu uzrokovanom općim anesteticima zbog toga što uzrokuje komplikacije nakon 
operacije i usporava oporavak. Oksidacijski stres nastaje kada je stvaranje reaktivnih kisikovih spojeva (ROS) veće od 
stanične zaštite antioksidansima. Poznavanje učinka anestetika na oksidacijski stres posebice je važno pri planiranju 
kirurških zahvata kod kojih je poznato da uzrokuju nastanak veće količine ROS-a. Naime, antagonistički ili aditivni 
učinak anestetika na oksidacijski stres može kod takvih kirurških zahvata biti ključan za ishod operacije. Brojna su 
istraživanja o toj temi, no protokoli pokusa na staničnim kulturama i pokusnim životinjama vrlo su različiti. U istraživanjima 
na ljudima anestetici su upotrebljavani tijekom vrlo raznorodnih kirurških zahvata, često uz primjenu više anestetika, 
mjereni su različiti parametri oksidacijskoga stresa, a uzorci (najčešće krvi) uzimani su obično prije zahvata i u različitim 
intervalima nakon njega. Zbog svega je toga ponekad teško razlučiti kakav je učinak nekog anestetika na oksidacijski 
stres. Općenito intravenozni anestetici imaju antioksidacijsko djelovanje, imaju ga i plinoviti anestetici – uglavnom nakon 
kratkotrajne anestezije, a dugotrajna anestezija uzrokuje privremeni porast oksidacijskoga stresa.
KLJUČNE RIJEČI: glutation; malondialdehid; reaktivni kisikovi spojevi; SOD; TBARS
